EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 7 November 2024

News

Joint statement from the human pharmaceutical industry on the Urban Wastewater Treatment Directive...
05 November 2024

EFPIA and AESGP, representing the human pharmaceutical industry in Europe, acknowledge, with some reservations, the... Read more

Advancing the precision oncology agenda in the EU

Access to precision oncology is crucial for timely, effective cancer treatment. Yet, access challenges reveal disparities across European countries. The various precision oncology multi-stakeholder initiatives led by the European Commission can help address the challenges faced by cancer patients and healthcare providers at a country level.

Join us on 13 November to explore how we can optimise the link between European initiatives and local challenges.

Events

Innovating for Impact: Shaping the Future of Rare Disease Treatment
12 November 2024 (Virtual event)

This Euronews debate will look deeper into what needs to be done at the research and policy level. Read more

Brokerage event for IHI’s 2025 calls
12 November 2024 (Brussels, Belgium)

Join IHI's 2025 calls for proposals. This event will give you the opportunity to network, collaborate, and start forming... Read more

Antimicrobial resistance is invisible, I am not
18 November 2024 (Virtual event)

Organised by the European Centre for Disease Prevention and Control Read more

IMAGINE a healthier, more competitive Europe
10 December 2024 (Brussels & Online)

Register now to reserve your seat. Read more

What we are reading

Why the future of European healthcare depends on greater investment
On 04 November 2024 (Financial Times)

Supporting innovation remains an astute way to tackle disease, promote well-being and... Read more

EMA Should Lead AI Oversight In Pharma & Align With Global Regulators, Says EFPIA
On 29 October 2024 (Pink Sheet)

EFPIA has set out six key recommendations for regulating the use of AI in the medicinal product lifecycle in the... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu